Zech Michael, Castrop Florian, Schormair Barbara, Jochim Angela, Wieland Thomas, Gross Nadine, Lichtner Peter, Peters Annette, Gieger Christian, Meitinger Thomas, Strom Tim M, Oexle Konrad, Haslinger Bernhard, Winkelmann Juliane
Neurologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany; Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany.
Mov Disord. 2014 Oct;29(12):1504-10. doi: 10.1002/mds.25981. Epub 2014 Aug 20.
Recessive DYT16 dystonia associated with mutations in PRKRA has until now been reported only in seven Brazilian patients. The aim of this study was to elucidate the genetic cause underlying disease in a Polish family with autosomal-recessive, early-onset generalized dystonia and slight parkinsonism, and to explore further the role of PRKRA in a dystonia series of European ancestry. We employed whole-exome sequencing in two affected siblings of the Polish family and filtered for rare homozygous and compound heterozygous variants shared by both exomes. Validation of the identified variants as well as homozygosity screening and copy number variation analysis was carried out in the two affected individuals and their healthy siblings. PRKRA was analyzed in 339 German patients with various forms of dystonia and 376 population-based controls by direct sequencing or high-resolution melting. The previously described homozygous p.Pro222Leu mutation in PRKRA was found to segregate with the disease in the studied family, contained in a 1.2 Mb homozygous region identical by state with all Brazilian patients in chromosome 2q31.2. The clinical presentation with young-onset, progressive generalized dystonia and mild parkinsonism resembled the phenotype of the original DYT16 cases. PRKRA mutational screening in additional dystonia samples revealed three novel heterozygous changes (p.Thr34Ser, p.Asn102Ser, c.-14A>G), each in a single subject with focal/segmental dystonia. Our study provides the first independent replication of the DYT16 locus at 2q31.2 and strongly confirms the causal contribution of the PRKRA gene to DYT16. Our data suggest worldwide involvement of PRKRA in dystonia.
与PRKRA基因突变相关的隐性DYT16肌张力障碍迄今为止仅在7名巴西患者中被报道。本研究的目的是阐明一个患有常染色体隐性、早发性全身性肌张力障碍和轻度帕金森症的波兰家族中该疾病的潜在遗传病因,并进一步探索PRKRA在欧洲血统的肌张力障碍系列中的作用。我们对这个波兰家族的两名患病兄弟姐妹进行了全外显子测序,并筛选了两个外显子共有的罕见纯合和复合杂合变异。对两名患病个体及其健康的兄弟姐妹进行了已鉴定变异的验证以及纯合性筛选和拷贝数变异分析。通过直接测序或高分辨率熔解对339名患有各种形式肌张力障碍的德国患者和376名基于人群的对照进行了PRKRA分析。在研究的家族中发现,先前描述的PRKRA基因纯合p.Pro222Leu突变与疾病共分离,该突变位于2号染色体2q31.2上一个1.2 Mb的纯合区域,与所有巴西患者的该区域状态相同。其临床表现为早发性、进行性全身性肌张力障碍和轻度帕金森症,与最初的DYT16病例表型相似。对其他肌张力障碍样本进行的PRKRA突变筛查发现了三个新的杂合变化(p.Thr34Ser、p.Asn102Ser、c.-14A>G),每个变化都存在于一名患有局灶性/节段性肌张力障碍的个体中。我们的研究首次独立验证了2q31.2处的DYT16位点,并有力地证实了PRKRA基因对DYT16的病因学贡献。我们的数据表明PRKRA在全球范围内都与肌张力障碍有关。